Back to search

University of Ioannina

Συσχέτιση βιολογικών και ψηφιακών βιοδεικτών στη νόσο Πάρκινσον

Abstract

dc:description

Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by heterogeneous motor and non-motor manifestations and variable rates of progression. The lack of reliable, minimally invasive biomarkers capable of capturing disease progression remains a major barrier to personalized management and evaluation of disease-modifying interventions. Digital health technologies and blood-based biomarkers, particularly exosome-derived proteins, offer complementary approaches for longitudinal disease monitoring. This prospective, single-arm clinical study followed patients with Parkinson’s disease over a 2 years period. Participants were remotely monitored using a wearable telemonitoring system. Clinical assessments were conducted at 0, 12 and 24 months and included standardized scales evaluating motor symptoms, non-motor symptoms, cognitive function, and quality of life. The accuracy and sensitivity of the telemonitoring device in detecting longitudinal motor symptom changes were evaluated against established clinical scales. In parallel, peripheral blood samples were collected longitudinally. Exosomes were isolated using differential ultracentrifugation and their protein content was analyzed using liquid chromatography tandem mass spectrometry (LC-MS/MS). Differential protein expression analyses were performed across time points, and associations between proteomic changes and clinical outcomes were explored. Telemonitoring data demonstrated sensitivity to changes in motor symptoms over time and showed meaningful concordance with established clinical motor assessments, supporting the device’s ability to detect subtle longitudinal changes. Clinically, patients exhibited significant improvement from the first 12 months across motor, non-motor, cognitive, and quality-of-life domains, underscoring the significant effectiveness of the intervention. Proteomic analysis of circulating exosomes identified a subset of proteins showing significant expression changes over the 12-month follow-up. Several of these proteins were implicated in biological pathways relevant to neurodegeneration, inflammation, and cellular stress. Importantly, selected exosomal proteins demonstrated significant associations with changes in clinical scale scores, suggesting a link between molecular alterations and clinical progression. This study demonstrates the feasibility and added value of integrating digital telemonitoring with longitudinal exosome-based proteomics in Parkinson’s disease. Objective, continuous motor data complemented traditional clinical assessments and enhanced the characterization of disease dynamics. The identification of exosomal proteins that change over time and correlate with clinical outcomes supports their potential role as biomarkers of disease progression. Together, these findings highlight a multimodal framework that combines digital biomarkers and peripheral molecular signatures to improve monitoring of Parkinson’s disease and to support the development of personalized, disease-modifying strategies. Further validation in larger, controlled cohorts is warranted to establish the robustness and clinical utility of the identified candidate biomarkers.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kanellos, Foivos
  • Κανέλλος, Φοίβος

Subjects

dc:subject × 24

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61779

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kanellos, Foivos; Κανέλλος, Φοίβος. Συσχέτιση βιολογικών και ψηφιακών βιοδεικτών στη νόσο Πάρκινσον. University of Ioannina, 2025. http://hdl.handle.net/10442/hedi/61779